Table 1.
Clinical characteristics in the different datasets.
| Discovery* | Validation | |||
|---|---|---|---|---|
| Entire set | Training set | Test set | Validation set | |
| Number of patients | 708 | 496 | 212 | 36 |
| Age, months | 27.0 (9.0–59.0) | 27.0 (9.0–54.0) | 29.0 (8.0–66.0) | NA |
| Sex | ||||
| Male | 417 (58.9) | 291 (58.7) | 126 (59.4) | 23 (63.9) |
| Female | 291 (41.1) | 205 (41.3) | 86 (40.6) | 13 (36.1) |
| Outcome | ||||
| Kawasaki disease | 300 (42.4) | 210 (42.3) | 90 (42.5) | 23 (63.9) |
| Febrile controls | 408 (57.6) | 286 (57.7) | 122 (57.5) | 13 (36.1) |
| Pathogens in febrile controls | ||||
| Definite bacterial | 92 (22.5) | 70 (24.5) | 22 (18.0) | 8 (61.5) |
| Definite viral | 141 (34.6) | 95 (33.2) | 46 (37.7) | 5 (38.5) |
| Uncertain | 175 (42.9) | 121 (42.3) | 54 (44.3) | 0 |
Data are presented as median (IQR), or n (%); NA, not applicable.
*
There were no significant differences between children in Training and Test sets.